Curis Lifesciences IPO Allotment Date
As per the timeline, the Curis Lifesciences IPO allotment date is November 12, 2025, Wednesday. The investors can check the IPO allotment via the registrar website of MUFGIntime or the NSE website. Investors can check the allotment status online and offline with easy steps given below:
Curis Lifesciences IPO Allotment Links
| Registrar: | MUFGIntime IPO Allotment Page |
| NSE: | NSE IPO Allotment Page |
| IPO Watch: | IPO Allotment Status Page |
Check Curis Lifesciences’ IPO Allotment Status on Registrar site?
- Visit MUFG Intime India Pvt. Ltd. website
- Select IPO Name ‘Curis Lifesciences’ from the drop-down menu on the page
- Enter details required like PAN Card, Application Number, or Demat Account Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Curis Lifesciences IPO Allotment Status on NSE?
- Visit NSE India IPO Allotment Page
- Select the issue type
- Select IPO Name ‘Curis Lifesciences’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
IPO Subscription Details
| Category | Day 1 | Day 2 | Day 3 |
| QIB | 8.34 | 8.34 | 96.17 |
| NII | 1.19 | 4.06 | 115.46 |
| RII | 0.86 | 3.75 | 44.28 |
| Total | 3.07 | 5.13 | 74.39 |
Curis Lifesciences IPO Key Dates
| IPO Open Date: | November 7, 2025 |
| IPO Close Date: | November 11, 2025 |
| Basis of Allotment: | November 12, 2025 |
| Refunds: | November 13, 2025 |
| Credit to Demat Account: | November 13, 2025 |
| IPO Listing Date: | November 14, 2025 |
Business Overview
Curis Lifesciences Limited, founded in 2010, is one of the leading pharmaceutical companies that manufactures a wide range of pharmaceutical products, including Tablets, Capsules, External Preparations, Oral liquids, and Sterile Ophthalmic Ointments. The company gets ready-made goods from manufacturers and distributes them to wholesalers and other clients nationwide. The company had a total of 95 permanent employees as of July 31, 2025.
Curis Lifescience makes medicine in India and abroad under contract or license agreement, as well as for its own brand. In addition to its two own-brand clients in Yemen and Kenya, the firm contracts with more than 100 corporate clients. Moreover, the company consists of a state-of-the-art factory in Sanand, Gujarat, through which they follow strict quality control checks to make sure each of their products is safe and works well.
Note for the Investors
Curis Lifesciences IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Curis Lifesciences IPO Allotment date and time please contact the registrar with your queries.
